NCT02019212View on ClinicalTrials.gov

Prognostic Value of Stress SPECT Myocardial Perfusion Imaging With Half Dose 99mTc-Tetrofosmin

CompletedOBSERVATIONAL
Enrollment

4,000

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

October 27, 2016

Study Completion Date

October 27, 2016

Conditions
Cardiovascular Disease
Trial Locations (1)

K1Y 4W7

University of Ottawa Heart Insitute, Ottawa

All Listed Sponsors
lead

Ottawa Heart Institute Research Corporation

OTHER

NCT02019212 - Prognostic Value of Stress SPECT Myocardial Perfusion Imaging With Half Dose 99mTc-Tetrofosmin | Biotech Hunter | Biotech Hunter